This topic contains a solution. Click here to go to the answer

Author Question: Because assessment plays such a small role in solution building, De Jong and Berg do not think it is ... (Read 25 times)

NguyenJ

  • Hero Member
  • *****
  • Posts: 516
Because assessment plays such a small role in solution building, De Jong and Berg do not think it is worthwhile for interviewers to acquaint themselves with the problem-assessment instruments commonly used to assess clients life-sustaining and safety needs.
 
  Indicate whether the statement is true or false.

Question 2

In crisis situations, clients are generally dealing with threats to the needs which Maslow identified as most basic to human existence.
 
  Indicate whether the statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jasonq

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

F

Answer to Question 2

T




NguyenJ

  • Member
  • Posts: 516
Reply 2 on: Jul 30, 2018
YES! Correct, THANKS for helping me on my review


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library